2. Gene
  3. C6 - complement C6 Gene

C6 - complement C6 Gene

  • 基因
  • 蛋白
  • 疾病
  • 相关产品
  • 直系同源

中文名称：补体 C6

种属: Homo sapiens

基因 ID: 729 | 基因类型: protein coding

关于 C6

Cytogenetic location: 5p13.1 Genomic coordinates (GRCh38): 5:41,142,116-41,261,469 (from NCBI)

This gene has 9 transcripts (splice variants), 206 orthologues, 39 paralogues and is associated with 2 phenotypes. Biased expression in liver (RPKM 126.4), heart (RPKM 11.8) and 2 other tissues.

功能概要

该基因编码补体级联的一个组成部分。编码的蛋白质是膜攻击复合物的一部分，可以掺入细胞膜并引起细胞裂解。该基因的突变与补体成分 6 缺乏有关。已经描述了编码相同蛋白质的转录变体。[RefSeq 提供，2012 年 11 月]

This gene encodes a component of the complement cascade. The encoded protein is part of the membrane attack complex that can be incorporated into the cell membrane and cause Cell Lysis. Mutations in this gene are associated with complement component-6 deficiency. Transcript variants encoding the same protein have been described.[provided by RefSeq, Nov 2012]

C6 基因产物(2)

mRNA Protein Name
NM_000065.5 NP_000056.2 complement component C6 precursor
NM_001115131.4 NP_001108603.2 complement component C6 precursor

C6 蛋白结构

TSP_1

TSP_1: Thrombospondin type 1 domain (28 - 78)

TSP_1

TSP_1: Thrombospondin type 1 domain (86 - 133)

Ldl_recept_a

Ldl_recept_a: Low-density lipoprotein receptor domain class A (140 - 173)

MACPF

MACPF: MAC/Perforin domain (293 - 514)

TSP_1

TSP_1: Thrombospondin type 1 domain (571 - 612)

Sushi

Sushi: Sushi repeat (SCR repeat) (644 - 695)

Sushi

Sushi: Sushi repeat (SCR repeat) (713 - 754)

Kazal_2

Kazal_2: Kazal-type serine protease inhibitor domain (793 - 837)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 934 a.a.
蛋白主名 其他名称

complement component C6

complement component 6

重组 C6 蛋白

目录号 产品名 蛋白编号 纯度
HY-P74373 C6/Complement component C6 Protein, Human (HEK293, His) AAA59668 (M1-A934) ≥95%

关联疾病

疾病名称 别名
Complement Component 6 Deficiency

C6 Deficiency

C6D

C6 Deficiency Subtotal

Complement Component 6 Deficiency Subtotal

C6 Deficiency, Subtotal
Immunodeficiency Due To A Late Component Of Complement Deficiency

Immunodeficiency Due To C5 To C9 Component Complement Deficiency

Terminal Complement Pathway Deficiency
Meningococcal Meningitis

Meningitis, Meningococcal

Meningitis Meningococcal

Epidemic Meningitis

Meningitis Due To Neisseria Meningitidis

Meningococcal Meninges Infection

Meningococcal Meningeal Infection

Meningococcal Cerebrospinal Inflammation

Chronic Meningococcal Arachnoiditis

Meningococcal Arachnoiditis

Diplococcal Spinal Meningitis

Diplococcal Meningitis

Meningococcal Cerebrospinal Fever

Meningococcal Cerebrospinal Infection

Meningococcal Spinal Meningitis
疾病名称 别名
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

相关产品

Clinical Phase
生物活性分子 (2)
目录号 产品名 作用方式
纯度 Phase
HY-104036 IDH-305 Inhibitor 98.75% Phase 2
HY-N2037A Higenamine hydrochloride 99.68% Phase 1
Pre-clinical Phase
生物活性分子 (410)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-B0389A D-Glucose-13C6 ≥99.0% 否
HY-129047 Trypsin Activator / 否
HY-111997 VH285-PEG4-C4-Cl ≥98.0% 否
HY-100014 KDM5A-IN-1 Inhibitor 99.80% 否
HY-19542 C6 Ceramide Inducer ≥98.0% 否
HY-W096119 NH2-PEG2-C6-Cl ≥98.0% 否
HY-16594 Lactacystin Inhibitor 98.08% 否
HY-107836 Methiothepin mesylate Antagonist 99.60% 否
HY-N7092S D-Fructose-13C6 99.95% 否
HY-W011561 Boc-NH-C6-Br ≥98.0% 否
HY-140921 Biotin-PEG4-amino-t-Bu-DADPS-C6-azide ≥95.0% 否
HY-N1127 Tricin Inhibitor 99.87% 否
HY-112495 VH032-PEG5-C6-Cl 99.76% 否
HY-145442 8-Azanebularine Inhibitor ≥98.0% 否
HY-N6974 Ascr#2 ≥98.0% 否
HY-D0180 18-Crown-6-ether 99.57% 否
HY-N1428S1 Citric acid-13C6 ≥99.0% 否
HY-N0455AS8 L-Arginine-13C6,15N4 hydrochloride Activator ≥99.0% 否
HY-W008296 NH2-C6-NH-Boc 99.61% 否
HY-112496 Cl-C6-PEG4-O-CH2COOH ≥98.0% 否
HY-132004 Tos-O-C4-NH-Boc 97.03% 否
HY-140914 Biotin-PEG4-Amide-C6-Azide 99.11% 否
HY-119402 TP-021 Inhibitor 99.14% 否
HY-140314 DOTA-PEG5-C6-DBCO 96.40% 否
HY-N2038 3,​5,​6,​7,​8,​3',​4'-​Heptemthoxyflavone Inhibitor 99.85% 否
HY-N6076 Tenuifoliside A Inhibitor 98.07% 否
HY-135250B Thalidomide-4-O-C6-NH2 hydrochloride Inducer 98.53% 否
HY-113410 3-Methylglutaric acid ≥98.0% 否
HY-129622A NH2-PEG5-C6-Cl hydrochloride ≥98.0% 否
HY-103605 (S,R,S)-AHPC-C6-PEG3-C4-Cl 95.46% 否
HY-103608 (S,R,S)-AHPC-(C3-​PEG)​2-​C6-​Cl 98.85% 否
HY-138469 NH2-PEG3-C6-Cl ≥95.0% 否
HY-138470 Azido-PEG2-C6-Cl ≥95.0% 否
HY-N0455AS6 L-Arginine-13C6 hydrochloride Activator ≥98.0% 否
HY-W009762S L-Lysine-13C6,15N2 dihydrochloride 99.40% 否
HY-112537S1 D-Glucose 6-Phosphate-13C6 disodium xhydrate ≥98.0% 否
HY-113248S1 3-Nitro-L-tyrosine-13C6 ≥95.0% 否
HY-114165 DJ-V-159 Agonist 99.62% 否
HY-138521 Azido-C6-OH ≥95.0% 否
HY-N0379S22 D-Mannose-13C6 ≥98.0% 否
HY-N0470S3 L-Lysine-13C6,15N2 hydrochloride Inhibitor ≥98.0% 否
HY-W356116 C6 NBD Ceramide ≥99.0% 否
HY-121805 DBCO-​C6-​acid 97.02% 否
HY-129047A Trypsin (MS grade) Activator 95.00% 否
HY-135306 Cl-C6-PEG4-C3-COOH 99.65% 否
HY-136006B (S,R,S)-AHPC-C6-NH2 98.03% 否
HY-B0143S3 Niacin-13C6 Inducer ≥98.0% 否
HY-B0497S1 Niclosamide-13C6 Inhibitor ≥99.0% 否
HY-N0486S8 L-Leucine-13C6,15N Activator 99.90% 否
HY-P3146S FTISADTSK-13C6,15N2 TFA 99.02% 否
HY-W020768 Fullerene-C60 99.87% 否
HY-153785 NH2-C6-ARC186 sodium Inhibitor 92.50% 否
HY-126683 Mal-C6-α-Amanitin 98.48% 否
HY-130951 Thalidomide-O-C6-COOH Inducer 99.67% 否
HY-108971 Demecycline Inhibitor ≥98.0% 否
HY-124377 SPDP-C6-NHS ester 98.09% 否
HY-133689AS 3-Nitrophenylhydrazine-13C6 hydrochloride 98.26% 否
HY-139218 (S,R,S)-AHPC-Me-C6-NH2 98.81% 否
HY-144085S D-Fructose-6-phosphate-13C6 disodium x.hydrate ≥98.0% 否
HY-152039S1 6PPD-quinone-13C6 ≥98.0% 否
HY-16938S 5'-Methylthioadenosine-13C6 98.45% 否
HY-B0167S1 Salicylic acid-13C6 ≥97.0% 否
HY-B0322S1 Sulfamethoxazole-13C6 Inhibitor 99.65% 否
HY-N0210S16 D-Galactose-13C6 ≥98.0% 否
HY-N0486S2 L-Leucine-13C6 Activator ≥98.0% 否
HY-N0771S L-Isoleucine-13C6 ≥98.0% 否
HY-N2461 Ganoderic acid C6 98.15% 否
HY-112618A Thalidomide-O-amido-C6-NH2 TFA Inducer 99.82% 否
HY-129704A Thalidomide-NH-C6-NH2 TFA Inducer 99.82% 否
HY-130854 Thalidomide-NH-C6-NH-Boc Inducer 96.11% 否
HY-136006A (S,R,S)-AHPC-C6-NH2 hydrochloride / 否
HY-148129 TRPC6-IN-3 Inhibitor 99.62% 否
HY-106950S1 Fosfructose-13C6 tetrasodium hydrate 99.90% 否
HY-10715 SSR504734 Inhibitor 99.82% 否
HY-108226S1 Regorafenib N-oxide and N-desmethyl (M5)-13C6 ≥91.0% 否
HY-108372 Boc-C5-O-C5-O-C6-Cl / 否
HY-112499S1 Menaquinone-7-13C6 ≥96.0% 否
HY-129704B Thalidomide-NH-C6-NH2 hydrochloride Inducer 99.62% 否
HY-130621 OTs-C6-OBn 98.07% 否
HY-131887 Pomalidomide-C6-COOH 98.02% 否
HY-137905 Pomalidomide-amido-C5-PEG2-C6-chlorine 99.69% 否
HY-141939S Triiodothyronine-13C6( hydrochloride) 96.74% 否
HY-144677 pan-HER-IN-2 98.10% 否
HY-145245 TLR4-IN-C34-C2-amide-C6-OH Inhibitor ≥95.0% 否
HY-147622 GLP-1R agonist 9 Agonist / 否
HY-18569S4 3-Indoleacetic acid-13C6 ≥98.0% 否
HY-B0389S D-Glucose-13C6,d7 ≥98.0% 否
HY-B0400S16 D-Sorbitol-13C6 99.94% 否
HY-B1221S1 Flufenamic acid-13C6 / 否
HY-B1267S1 Sulfaguanidine-13C6 Inhibitor ≥99.0% 否
HY-D1432 FITC-C6-DEVD-FMK ≥97.0% 否
HY-D1574 C6 NBD Sphingomyelin ≥98.0% 否
HY-N0349S1 Methyl paraben-13C6 / 否
HY-N0684S3 Vitamin K1-13C6 ≥99.0% 否
HY-N7032S1 Uridine 5′-diphosphoglucose-13C6 disodium 98.35% 否
HY-W014225S 3-Phenoxybenzoic acid-13C6 99.29% 否
HY-W018291 Mal-C6-amine TFA ≥97.0% 否
HY-W103245 Benzo-18-crown-6-ether / 否
HY-W104010S 2-Chloroaniline hydrochloride-13C6 99.64% 否
HY-W129359 11β-HSD1-IN-8 ≥95.0% 否
HY-Y0051S 5-Hydroxymethylfurfural-13C6 / 否
HY-B0252S2 Hydrochlorothiazide-13C6 99.61% 否
HY-112618 Thalidomide-O-amido-C6-NH2 Inducer / 否
HY-129704 Thalidomide-NH-C6-NH2 Inducer / 否
HY-135250 Thalidomide-4-O-C6-NH2 Inducer / 否
HY-135250A Thalidomide-4-O-C6-NH2 TFA Inducer / 否
HY-125884 Pomalidomide-amido-C4-amido-C6-NH-Boc / 否
HY-131089 MC-VC-PABC-C6-alpha-Amanitin / 否
HY-136006 (S,R,S)-AHPC-C6-NH2 dihydrochloride / 否
HY-100532S CD437-13C6 Agonist / 否
HY-101064S1 Fmoc-leucine-13C6,15N Modulator / 否
HY-10163S2 Dabigatran-13C6 / 否
HY-10572S1 Efavirenz-13C6 / 否
HY-106950CS3 Fosfructose-6-13C sodium / 否
HY-10999S1 Trametinib-13C6 / 否
HY-111253 CYM-5478 Agonist / 否
HY-112586S1 Sulfaethoxypyridazine-13C6 Inhibitor / 否
HY-112618B Thalidomide-O-amido-C6-NH2 hydrochloride Inducer / 否
HY-113251S1 2-Hydroxyestrone-13C6 Inhibitor / 否
HY-113252S1 2-Methoxyestrone-13C6 / 否
HY-113296S Indoxyl sulfate-13C6 potassium / 否
HY-113410S 3-Methylglutaric acid-d4 / 否
HY-114750S Mebendazole-amine-13C6 / 否
HY-115584S Lufenuron-13C6 Inhibitor / 否
HY-116214S1 Cyprodinil-13C6 / 否
HY-116609 C6 L-threo Ceramide Inhibitor / 否
HY-117042 Biotin-PEG2-C6-azide 95.87% 否
HY-117275S1 Meclofenamic acid-13C6 Inhibitor / 否
HY-118645S3 1'-Hydroxymidazolam-13C6 / 否
HY-12008S1 Erlotinib-13C6 hydrochloride / 否
HY-12033S1 2-Methoxyestradiol-13C6 / 否
HY-121267S Dicamba-13C6 / 否
HY-122062S Fenoxycarb-13C6 / 否
HY-124489S 2-Hydroxyestradiol-13C6 / 否
HY-125296S Fipronil sulfone-13C6 / 否
HY-125888 Boc-NH-C6-amido-C4-acid / 否
HY-126373S1 SN-38 glucuronide-13C6 / 否
HY-12726S Liproxstatin-1-13C6 / 否
HY-128417S4 alpha-D-glucose-13C6 / 否
HY-128417S5 alpha-D-glucose-13C6,d7 / 否
HY-128417S6 alpha-D-glucose-13C6,d12 / 否
HY-12857S Brigatinib-13C6 Inhibitor / 否
HY-128790S1 4-Methoxyestrone-13C6 / 否
HY-129622 NH2-PEG5-C6-Cl / 否
HY-129656 GLP-1 receptor agonist 3 Agonist / 否
HY-129974S 3,3'-Diiodo-L-thyronine-13C6 / 否
HY-13078S Cobimetinib-13C6 racemate / 否
HY-131501S1 Menaquinone-9-13C6 / 否
HY-131682 3-C6-NBD-cholesterol / 否
HY-133694S 2-Aminoflubendazole-13C6 / 否
HY-13613S Dutasteride-13C6 / 否
HY-136380S Clodinafop-propargyl-13C6 / 否
HY-13690S1 Mitotane-13C6 / 否
HY-137912S1 Resveratrol-3-O-beta-D-glucuronide-13C6 / 否
HY-138307 NH2-PEG-Strt (MW 10000) / 否
HY-138308 NH2-PEG-Strt (MW 3000) / 否
HY-138310 Thiol-PEG-COOH (MW 5000) / 否
HY-138311 Boc-NH-PEG-Thiol (MW 10000) / 否
HY-138466 Azido-PEG3-C6-Cl ≥95.0% 否
HY-138471 Azido-PEG2-C6-OH / 否
HY-138622S 24:0 Lyso PC-13C6 / 否
HY-138852 Thalidomide-NH-amido-C6-NH2 Inducer / 否
HY-138852A Thalidomide-NH-amido-C6-NH2 hydrochloride Inducer / 否
HY-139921S1 Nordiazepam-13C6 / 否
HY-141123 SPDP-C6-Gly-Leu-NHS ester / 否
HY-141315 m-PEG6-C6-phosphonic acid ethyl ester / 否
HY-141576 C6-NBD Sphinganine / 否
HY-141887 Thalidomide-O-C6-NHBoc Inducer 95.07% 否
HY-141909S 4-Fluoroiodobenzene-13C6 / 否
HY-141919S 1-Bromo-4-iodobenzene-13C6 / 否
HY-141928S 4-Bromoanisole-13C6 / 否
HY-143830 t-Boc-N-amido-PEG2-C6-Cl / 否
HY-143843S Isosorbide-2-mononitrate-13C6 / 否
HY-143857S 22:0 Lyso PC-13C6 / 否
HY-143876S L-Argininosuccinic acid-13C6,15N4 barium, dihydrate / 否
HY-144825 Chol-CTPP Inducer / 否
HY-14538S3 Haloperidol-13C6 Antagonist / 否
HY-146002 IDH2R140Q-IN-1 Inhibitor / 否
HY-146687 BuChE-IN-4 Inhibitor / 否
HY-146807 Type II TRK inhibitor 1 Inhibitor / 否
HY-146966S 2-NP-DNSAH-13C6 / 否
HY-146967S 4-(3,6-Dimethylhept-3-yl)phenol-13C6 / 否
HY-146968S Alloerythro-Isoxsuprine-13C6 hydrochloride / 否
HY-146969S Bisdesoxyquinoceton-13C6 / 否
HY-146972S Zearalenone-14-O-β-glucoside-13C6 / 否
HY-147178 C-6 NBD-dihydro-Ceramide / 否
HY-147516 SARS-CoV-2-IN-21 Inhibitor / 否
HY-148143 Pomalidomide-C6-NHS ester / 否
HY-148153 C6-Amide-(PEG)n-CH3 / 否
HY-148154 Poly(oxy-1,2-ethanediyl)-propoxy-amide-C6 / 否
HY-148362 Pomalidomide-C6-O-C5-O-C4-COOH 98.55% 否
HY-148556 Thalidomide-O-C6-azide 99.71% 否
HY-15027S2 5-Aminosalicylic acid-13C6 / 否
HY-15036S1 Diclofenac-13C6 / 否
HY-15037S Diclofenac-13C6 sodium heminonahydrate / 否
HY-15037S2 Diclofenac-13C6 sodium / 否
HY-150626 SARS-CoV-2 nsp13-IN-5 Inhibitor / 否
HY-150679S Remdesivir-13C6 / 否
HY-150703S DL-4-Methoxyestradiol-13C6 / 否
HY-150706S D-fructose-6-phosphate-13C6 / 否
HY-150978 DDAO-C6 / 否
HY-151271 SARS-CoV-2-IN-27 Inhibitor / 否
HY-151271A SARS-CoV-2-IN-27 disodium Inhibitor / 否
HY-151791 (S,R,S)-AHPC-C6-PEG3-butyl-N3 / 否
HY-155141 hCYP3A4-IN-1 Inhibitor / 否
HY-155262 Pomalidomide-5-C6-NH2 hydrochloride / 否
HY-15550S1 4'-Hydroxy diclofenac-13C6 / 否
HY-155593 JNK-1-IN-2 Inhibitor / 否
HY-156341S1 LLIYYTSSLHSGVPSR-(Arg-13C6,15N4) (TFA) / 否
HY-156343S1 SNNYATHYAESVK-(Lys-13C6,15N2) (TFA) / 否
HY-156344S1 GLEWVAEIR-(Arg-13C6,15N4) (TFA) / 否
HY-156345S1 LPFTFGQGTK-(Lys-13C6,15N2) (TFA) / 否
HY-161012 RB-07-16 Inhibitor / 否
HY-162295 SARS-CoV-2-IN-83 Inhibitor / 否
HY-162342 Topoisomerase I inhibitor 14 Inhibitor / 否
HY-162370 CYP51-IN-16 Inhibitor / 否
HY-163422S PHSHPALTPEQK-(Lys-13C6,15N2) / 否
HY-163423S TELAEPTSTR-(Arg-13C6,15N4) / 否
HY-163424S SSVFVADPK-(Lys-13C6,15N2) / 否
HY-163425S AILNYVANK-(Lys-13C6,15N2) / 否
HY-163426S AFFGHYLYEVAR-(Arg-13C6,15N4) / 否
HY-163427S FNLEALVTHTLPFEK-(Lys-13C6,15N2) / 否
HY-16561S1 Resveratrol-13C6 / 否
HY-16561S2 (E/Z)-Resveratrol-13C6 / 否
HY-17453S1 Salmeterol-13C6 xinafoate Agonist / 否
HY-17596S Closantel-13C6 Inhibitor / 否
HY-17598S Rafoxanide-13C6 Inhibitor / 否
HY-18341S1 Thyroxine hydrochloride-13C6 / 否
HY-18341S2 L-Thyroxine-13C6 / 否
HY-18341S3 L-Thyroxine-13C6,15N / 否
HY-18341S4 L-Thyroxine-13C6-1 / 否
HY-18572S 2,4-D-13C6 Inhibitor / 否
HY-19542S Ceramide C6-d7 Inducer / 否
HY-19821S1 Fmoc-Ile-OH-13C6,15N / 否
HY-22306S β-D-Glucose pentaacetate-13C6 / 否
HY-23641 NH-bis(C1-Boc) / 否
HY-34428S 4-Fluorobenzonitrile-13C6 / 否
HY-44630 VH 032 amide-alkylC6-acid / 否
HY-50896S1 Erlotinib-13C6 / 否
HY-76929S tert-Butyl 4-aminobenzoate-13C6 / 否
HY-78131S3 Ibuprofen-13C6 / 否
HY-79131S Fmoc-Phe-OH-13C6 / 否
HY-79576S2 NSC 88911-13C6 / 否
HY-A0070AS2 Liothyronine-13C6-1 Agonist / 否
HY-A0130S Sulfalene-13C6 Inhibitor ≥99.0% 否
HY-A0132S12 N-Acetyl-D-glucosamine-13C6 / 否
HY-A0161S Chlophedianol-13C6 / 否
HY-B0035S2 Sulfamethazine-13C6 / 否
HY-B0141S4 Estradiol-13C6 Agonist / 否
HY-B0141S7 rel-Estradiol-13C6 / 否
HY-B0150S2 Nicotinamide-13C6 Inhibitor / 否
HY-B0152S2 Adenine-13C5,15N5 Chemical / 否
HY-B0152S3 Adenine-13C5 Chemical / 否
HY-B0166S L-Ascorbic acid-13C6 / 否
HY-B0166S8 L-Ascorbic acid-13C6-1 / 否
HY-B0213S1 Sulfameter-13C6 Inhibitor / 否
HY-B0221S Amphotericin B-13C6 / 否
HY-B0263S1 Thiabendazole-13C6 Inhibitor / 否
HY-B0273S1 Sulfadiazine-13C6 Inhibitor / 否
HY-B0335S1 Tolfenamic acid-13C6 Inhibitor / 否
HY-B0337S2 Sulfadimethoxine-13C6 Inhibitor / 否
HY-B0467AS Amoxicillin-13C6 Inhibitor / 否
HY-B0493S1 Niflumic acid-13C6 Inhibitor / 否
HY-B0497BS Niclosamide-13C6 monohydrate / 否
HY-B0574S2 Mefenamic acid-13C6 Inhibitor / 否
HY-B0822S1 Fipronil-13C6 / 否
HY-B0843S Metalaxyl-13C6 Inhibitor / 否
HY-B0892S3 Benzyl alcohol-13C6 / 否
HY-B0925S Oxacillin-13C6 sodium Inhibitor / 否
HY-B0946S2 Sulfamonomethoxine-13C6 Inhibitor / 否
HY-B0947S1 Sulfanitran-13C6 Inhibitor / 否
HY-B0975S Penicillin V-13C6 potassium Inhibitor / 否
HY-B1008S1 4-Aminobenzoic acid-13C6 / 否
HY-B1355AS1 Oxyphenbutazone-13C6 Inhibitor / 否
HY-B1409S Isosorbide dinitrate-13C6 / 否
HY-B1422S 9-Aminoacridine-13C6 Inhibitor / 否
HY-B1431S1 Butylparaben-13C6 / 否
HY-B1436S1 Nifuroxazide-13C6 Inhibitor / 否
HY-B1456AS Fenoprofen-13C6(sodium salt hydrate) / 否
HY-B1703S Nifursol-13C6 Inhibitor 99.60% 否
HY-B1779S5 Sucrose-13C6 / 否
HY-B1781S Sulfachloropyridazine-13C6 Inhibitor / 否
HY-B2156S1 Menaquinone-4-13C6 / 否
HY-B2236S1 DL-Lysine-13C6 hydrochloride / 否
HY-B2236S2 DL-Lysine-13C6,15N2 hydrochloride / 否
HY-D1433 FITC-C6-LEHD-FMK / 否
HY-D1573 C6 NBD Phytoceramide / 否
HY-D1575 C6 NBD Galactosylceramide / 否
HY-D1576 C6 NBD L-threo-dihydroceramide / 否
HY-D1577 C6 NBD Lactosylceramide / 否
HY-D1749 C6 NBD L-threo-ceramide / 否
HY-E70037 GlcNAc kinase (EcNagK) / 否
HY-I0210S 4-Iodoaniline-13C6 / 否
HY-N0086S2 N6-Methyladenosine-13C4 Inhibitor / 否
HY-N0086S3 N6-Methyladenosine-13C3 Inhibitor / 否
HY-N0098S2 Vanillin-13C6 / 否
HY-N0215S8 L-Phenylalanine-13C6 Antagonist / 否
HY-N0216S1 Benzoic acid-13C6 Inhibitor ≥98.0% 否
HY-N0304S1 L-DOPA-13C6 / 否
HY-N0378S2 D-Mannitol-13C6 / 否
HY-N0379S18 D-Mannose-13C6,d7 / 否
HY-N0384S3 Homovanillic acid-13C6,18O / 否
HY-N0455AS4 L-Arginine-13C6,15N4,d7 hydrochloride Activator / 否
HY-N0469S1 L-Lysine-13C6 dihydrochloride Inhibitor 98.70% 否
HY-N0470S1 L-Lysine-13C6,15N2,d9 dihydrochloride Inhibitor / 否
HY-N0470S8 L-Lysine-13C6 hydrochloride / 否
HY-N0473S2 L-Tyrosine-13C6 99.90% 否
HY-N0683S α-Vitamin E-13C6 Inhibitor / 否
HY-N0733S3 Glucosamine-6-13C hydrochloride / 否
HY-N0733S5 Glucosamine-13C6,15N hydrochloride / 否
HY-N0771S5 L-Isoleucine-13C6,15N,d10 / 否
HY-N0832S1 L-Histidine-13C6,15N3 Inhibitor / 否
HY-N0832S1A L-Histidine-13C6,15N3 hydrochloride / 否
HY-N10192 Aculene D Inhibitor / 否
HY-N11137 3′-Omethyl-5′-hydroxydiplacone Inhibitor / 否
HY-N1127S Tricin-d6 / 否
HY-N12396 Cyclosporin U / 否
HY-N1380S2 Guaiacol-13C6 / 否
HY-N1393S 2-Methoxybenzoic acid-13C6 / 否
HY-N1394S p-Anisic acid-13C6 Inhibitor / 否
HY-N7092S13 D-Fructose-13C6,d7 / 否
HY-N7123S1 Sulfacetamide-13C6 Inhibitor / 否
HY-N7147 Irisquinone / 否
HY-N7464 Jolkinolide E / 否
HY-N7745S2 Glucosylsphingosine-13C6 / 否
HY-N8462 6-O-Nicotinoylscutebarbatine G / 否
HY-N8588 Methyl ganoderate C6 / 否
HY-N9454 Garcinoic acid / 否
HY-P0014S2 Liraglutide-13C6,15N TFA / 否
HY-P2625S GLP-2(3-33) (Leu-13C6,15N) / 否
HY-P2625S1 GLP-2(3-33) (Leu-13C6,15N) (TFA) / 否
HY-P4596S H-Gly-Arg-OH (Arg-13C6,15N4) / 否
HY-P4596S1 H-Gly-Arg-OH (Arg-13C6,15N4) (TFA) / 否
HY-P5168S GPSVFPLAPSSK-13C6 / 否
HY-P5190S RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE / 否
HY-P5190S1 RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE TFA / 否
HY-P5201S VTSEGAGLQLQK-13C6,15N2 / 否
HY-P5201S1 VTSEGAGLQLQK-13C6,15N2 TFA / 否
HY-RS01752 C6 Human Pre-designed siRNA Set A / 否
HY-RS05970 H3C6 Human Pre-designed siRNA Set A / 否
HY-RS05978 H4C6 Human Pre-designed siRNA Set A / 否
HY-W001138S 4-Bromobenzaldehyde-13C6 / 否
HY-W007318S 2-Iodoaniline-13C6 / 否
HY-W008253S3 5-Hydroxyindole-3-acetic acid-13C6 / 否
HY-W008452S H-Tyr(3-I)-OH-13C6 / 否
HY-W008642S (Leu-13C6,15N)-Leu-OH TFA / 否
HY-W009048 Dicyclohexano-18-crown-6-ether / 否
HY-W009300S1 4-Hydroxyestrone-13C6 / 否
HY-W009597S 1,5-Dichloro-2,4-dinitrobenzene-13C6 / 否
HY-W010042S3 L-Glucose-13C6 / 否
HY-W010696AS Reverse T3-13C6 hydrochloride / 否
HY-W012530S Phenylpyruvic acid-13C6 sodium / 否
HY-W013396S 4-Iodobenzoic Acid-13C6 / 否
HY-W013677S 4-Fluorobenzoic acid-13C6 / 否
HY-W014223S 2,4-Dihydroxybenzophenone-13C6 / 否
HY-W014375S1 Arginine-13C6,15N4,d7 hydrochloride / 否
HY-W014375S2 Arginine-13C6 hydrochloride / 否
HY-W014375S4 Arginine-13C6,15N4 hydrochloride / 否
HY-W014423S1 L-Histidine-13C6,15N3,d5 hydrochloride hydrate / 否
HY-W014423S2 L-Histidine-13C6 hydrochloride hydrate / 否
HY-W014423S3 L-Histidine-13C6,15N3 hydrochloride hydrate / 否
HY-W014632S 4-Trifluoromethylsalicylic acid-13C6 / 否
HY-W015198S 4-(Trifluoromethyl)benzoic acid-13C6 / 否
HY-W017522S1 Adipic acid-13C6 / 否
HY-W017529S 6-Chloro-1,3,5-triazine-2,4-diamine-13C3 / 否
HY-W018386S 3-​Bromo-​L-​tyrosine-13C6 / 否
HY-W041171S 3-Chloro-L-tyrosine-13C6 / 否
HY-W050145S2 Levoglucosan-13C6 / 否
HY-W069721S1 N-Acetylsulfanilamide-13C6 / 否
HY-W092298S Methyl 4-(2-hydroxyethyl)benzoate-13C6,d2 / 否
HY-W104549S 3,6-Dichloro-2-hydroxybenzoic acid-13C6 / 否
HY-W156511S Diacetylsulfanilamide-13C6 / 否
HY-W243018S 1,2:5,6-Di-O-isopropylidene-a-D-glucofuranose-1,2,3,4,5,6-13C6 / 否
HY-W269700S Ile-(Leu-13C6,15N)-OH TFA / 否
HY-W278861S Desoxy-Mequindox-13C6 / 否
HY-W280531S DNSAH-13C6 ≥99.0% 否
HY-W344468S Adipate-13C6 sodium / 否
HY-W356117 C6 NBD Glucosylceramide ≥98.0% 否
HY-W584531 VH032-C6-NH-Boc / 否
HY-W653798 Hexachlorobenzene-13C6 / 否
HY-W768340 Sucrose-13C6-1 / 否
HY-W777456 Phenanthrene-13C6 / 否
HY-W777457 Anthracene-13C6 / 否
HY-W777535S Naphthalene-13C6 / 否
HY-W780293 2-Phenylphenol-13C6 / 否
HY-Y0589S m-Cyanobenzoic acid-13C6 / 否
HY-Y0721S 3-Bromofluorobenzene-13C6 / 否
HY-Y0931S 3-Iodobenzoic Acid-13C6 / 否
HY-Y1027S1 2-Chlorobenzoic acid-13C6 / 否
HY-Y1152S Fluorobenzene-13C6 / 否
HY-Y1636S1 L-Arginine-N-FMOC PBF-OH-13C6 / 否
HY-13948BS Angiotensin II human-13C6,15N TFA 98.11% 否
HY-143704S 5-Aminosalicylic acid-13C6 hydrochloride / 否
HY-149563 Thalidomide-5-O-C6-NH2 hydrochloride / 否
HY-151792 Pomalidomid-C6-PEG3-butyl-N3 / 否
HY-153542 AP-C6 Inhibitor / 否
HY-79128S1 Fmoc-L-Lys (Boc)-OH-13C6,15N2 Inhibitor / 否
HY-B0174AS Olsalazine-13C6 / 否
HY-B0190S1 Nafamostat formate salt-13C6 / 否
HY-N0455AS11 L-Arginine-13C6,d14 hydrochloride / 否
HY-N0771S9 L-Isoleucine-13C6,15N / 否
HY-N3622 Corchoionoside C / 否
HY-P3003S Cereulide-13C6 / 否
HY-W010209S DL-Histidine-13C6,15N3 / 否
HY-W016814S (Z)-Aconitic acid-13C6 / 否
HY-W101298S (Leu-13C6,15N)-Ile-OH TFA / 否
HY-W777681 Triflusal-13C6 / 否
HY-111543 AN11251 Inhibitor / 否
HY-101009 Methiothepin maleate Antagonist / 否
HY-111824 VH032-thiol-C6-NH2 / 否
抗体抑制剂 (1)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P99832 Cosfroviximab 95.00% 否

直系同源

种属 基因名 来源 基因 ID
Bos taurus C6 VGNC VGNC:52722
Felis catus C6 VGNC VGNC:60233
Rattus norvegicus C6 RGD RGD:2238
Canis familiaris C6 VGNC VGNC:38598
Macaca mulatta C6 VGNC VGNC:70477
Mus musculus C6 MGD MGI:88233
Macaca fascicularis C6 NCBI
Others C6 NCBI
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z